82 related articles for article (PubMed ID: 26588820)
1. Comparative proteomic profiling of Hodgkin lymphoma cell lines.
Vergara D; Simeone P; De Matteis S; Carloni S; Lanuti P; Marchisio M; Miscia S; Rizzello A; Napolitano R; Agostinelli C; Maffia M
Mol Biosyst; 2016 Jan; 12(1):219-32. PubMed ID: 26588820
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
[TBL] [Abstract][Full Text] [Related]
3. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.
Van Vlierberghe P; De Weer A; Mestdagh P; Feys T; De Preter K; De Paepe P; Lambein K; Vandesompele J; Van Roy N; Verhasselt B; Poppe B; Speleman F
Br J Haematol; 2009 Dec; 147(5):686-90. PubMed ID: 19775296
[TBL] [Abstract][Full Text] [Related]
4. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
Schneider EM; Torlakovic E; Stühler A; Diehl V; Tesch H; Giebel B
J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma are highly dependent on oxidative phosphorylation.
Birkenmeier K; Dröse S; Wittig I; Winkelmann R; Käfer V; Döring C; Hartmann S; Wenz T; Reichert AS; Brandt U; Hansmann ML
Int J Cancer; 2016 May; 138(9):2231-46. PubMed ID: 26595876
[TBL] [Abstract][Full Text] [Related]
6. Surfaceome of classical Hodgkin and non-Hodgkin lymphoma.
Hofmann A; Thiesler T; Gerrits B; Behnke S; Sobotzki N; Omasits U; Bausch-Fluck D; Bock T; Aebersold R; Moch H; Tinguely M; Wollscheid B
Proteomics Clin Appl; 2015 Aug; 9(7-8):661-70. PubMed ID: 26076441
[TBL] [Abstract][Full Text] [Related]
7. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity.
Giefing M; Winoto-Morbach S; Sosna J; Döring C; Klapper W; Küppers R; Böttcher S; Adam D; Siebert R; Schütze S
PLoS One; 2013; 8(12):e84928. PubMed ID: 24376854
[TBL] [Abstract][Full Text] [Related]
9. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.
Bohle V; Döring C; Hansmann ML; Küppers R
Leukemia; 2013 Mar; 27(3):671-9. PubMed ID: 23174882
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the CD58 gene in classical Hodgkin lymphoma.
Schneider M; Schneider S; Zühlke-Jenisch R; Klapper W; Sundström C; Hartmann S; Hansmann ML; Siebert R; Küppers R; Giefing M
Genes Chromosomes Cancer; 2015 Oct; 54(10):638-45. PubMed ID: 26194173
[TBL] [Abstract][Full Text] [Related]
11. Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma.
Salipante SJ; Adey A; Thomas A; Lee C; Liu YJ; Kumar A; Lewis AP; Wu D; Fromm JR; Shendure J
Genes Chromosomes Cancer; 2016 Mar; 55(3):278-87. PubMed ID: 26650888
[TBL] [Abstract][Full Text] [Related]
12. STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line.
Baus D; Nonnenmacher F; Jankowski S; Döring C; Bräutigam C; Frank M; Hansmann ML; Pfitzner E
Leukemia; 2009 Oct; 23(10):1885-93. PubMed ID: 19440213
[TBL] [Abstract][Full Text] [Related]
13. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
[TBL] [Abstract][Full Text] [Related]
14. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
[TBL] [Abstract][Full Text] [Related]
15. Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting.
Fromm JR; Kussick SJ; Wood BL
Am J Clin Pathol; 2006 Nov; 126(5):764-80. PubMed ID: 17050074
[TBL] [Abstract][Full Text] [Related]
16. Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: classical Hodgkin lymphoma vs. Hodgkin-like ATLL.
Ohshima K; Karube K; Hamasaki M; Suefuji H; Tutiya T; Yamaguchi T; Suzumiya J; Kikuchi M
Int J Cancer; 2003 Sep; 106(5):706-12. PubMed ID: 12866030
[TBL] [Abstract][Full Text] [Related]
17. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines.
Giefing M; Arnemann J; Martin-Subero JI; Nieländer I; Bug S; Hartmann S; Arnold N; Tiacci E; Frank M; Hansmann ML; Küppers R; Siebert R
Br J Haematol; 2008 Sep; 142(6):916-24. PubMed ID: 18671701
[TBL] [Abstract][Full Text] [Related]
18. Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells.
Emmerich F; Theurich S; Hummel M; Haeffker A; Vry MS; Döhner K; Bommert K; Stein H; Dörken B
J Pathol; 2003 Nov; 201(3):413-20. PubMed ID: 14595753
[TBL] [Abstract][Full Text] [Related]
19. [The molecular pathology of classical Hodgkin lymphoma].
Asano N
Rinsho Ketsueki; 2015 Oct; 56(10):2024-31. PubMed ID: 26458441
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.
Eckerle S; Brune V; Döring C; Tiacci E; Bohle V; Sundström C; Kodet R; Paulli M; Falini B; Klapper W; Chaubert AB; Willenbrock K; Metzler D; Bräuninger A; Küppers R; Hansmann ML
Leukemia; 2009 Nov; 23(11):2129-38. PubMed ID: 19657361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
